Protara Therapeutics
TARA
48 hedge funds and large institutions have $161M invested in Protara Therapeutics in 2015 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
867% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 3
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
118% more funds holding
Funds holding: 22 → 48 (+26)
63% more capital invested
Capital invested by funds: $98.8M → $161M (+$62.2M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.97M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.99M |
| 3 |
State Street
Boston,
Massachusetts
|
+$731K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$658K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$382K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DPA
Devon Park Associates
|
-$3.79M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.28M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$465K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$116K |
TARA Hedge Fund Activity: Q2 2015 in Review
48 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q2 2015, worth a combined $161M — up 63% from $98.8M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new TARA positions and 3 closed out — a net gain of 26 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was RA Capital Management, adding an estimated $3.97M. The largest seller was Devon Park Associates, exiting entirely with an estimated $3.79M sold.
- 48 institutional investors held Protara Therapeutics (TARA) as of Q2 2015, up from 22 in Q1 2015.
- Funds reported $161M of Protara Therapeutics stock for Q2 2015, up 63% quarter-over-quarter.
- 29 funds opened new Protara Therapeutics positions in Q2 2015 and 3 closed out, a net change of +26 holders.
- The largest Protara Therapeutics buyer in Q2 2015 was RA Capital Management, an estimated $3.97M added.
- The largest Protara Therapeutics seller in Q2 2015 was Devon Park Associates, an estimated $3.79M sold.
Based on aggregated 13F filings for Q2 2015.